12:00 AM
Jun 15, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

GeneSTAT pathogen platform regulatory update

DxNA submitted an Emergency Use Authorization (EUA) application to FDA for its GeneSTAT pathogen platform to detect the...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >